Background: Bronchopulmonary dysplasia is an inflammatory lung disease that afflicts preterm infants requiring supplemental oxygen and is associated with impaired pulmonary angiogenesis. We tested the hypothesis that there is a critical threshold of inspired O 2 (FiO 2 ) that alters pulmonary angiogenesis. Methods: Within 2-6 h of birth, rat pups were exposed to 10%, 21%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 100% FiO 2 for 2 h. Mixed arterial-venous blood gases, serum and pulmonary levels of vascular endothelial growth factor (VEGF) and soluble VEGF receptor-1, and pulmonary angiogenesis gene profiles were determined. results: Po 2 increased with hyperoxia from 35.6 ± 5.0 (range: 31.5-39.8) at 10% O 2 to 108.5 ± 25.0 (range: 82.2-134.8) at 100% O 2 . Po 2 at 21% O 2 was 42. 4 ± 7.3 (range: 36.8-48
B
ronchopulmonary dysplasia (BPD), a chronic lung disease in extremely low gestational-age neonates, is a major cause of long-term hospitalization, slow growth, recurrent respiratory illness, or death (1, 2) . The cause of BPD is complex and involves oxidant injury, barotrauma/volutrauma from mechanical ventilation, chronic inflammation, and disordered repair in immature lungs (3) (4) (5) . The pathology of BPD includes inflammation, abnormal alveolarization, fibrosis, and vascular abnormalities (6) (7) (8) (9) (10) (11) . Pulmonary development occurs by two main processes, alveolarization and microvascular maturation. Microvascular development, which is essential for efficient gas exchange, is regulated by vascular endothelial growth factor (VEGF), which has been shown to be disrupted in BPD (12) (13) (14) . Exposure to high concentrations of oxygen during lung development results in lung injury characterized by alterations in capillary density, endothelial cell destruction, pulmonary inflammation, and inhibition of the process of alveolarization (15) (16) (17) (18) (19) .
VEGF is a potent, endothelial cell mitogen that stimulates vessel proliferation, migration, and tube formation leading to angiogenic growth of new blood vessels (15) (16) (17) (18) (19) . It is essential for angiogenesis during development; the deletion of a single allele arrests angiogenesis and causes embryonic lethality (20) (21) (22) . VEGF is highly regulated by oxygen. VEGF gene expression increases through several different mechanisms during hypoxia and decreases during hyperoxia. Tambunting et al. (23) have shown that VEGF and VEGF receptor mRNA expression are impaired in lungs of extremely preterm baboons developing BPD, contributing to the dysmorphic microvasculature and disrupted alveolarization. Furthermore, Hasan et al. (24) showed that VEGF levels are low and soluble VEGF receptor (sVEGFR)-1 levels are high at birth in the tracheal aspirates of preterm newborn infants who developed BPD later, suggesting that sVEGFR-1, the endogenous inhibitor of VEGF, may be a biological marker for BPD.
Infants dying from BPD have decreased VEGF levels in their lungs, particularly in the thickened septae (15) . This finding suggests that exposure to oxygen prevents VEGF signaling in the lungs, leading to arrested microvascular maturation and BPD. Studies have examined many combinations of oxygen exposure and the effects of hyperoxia and hypoxia on vasculogenesis. Most commonly, a fraction of inspired O 2 (FiO 2 ) of >0.95 was used with "recovery" from hyperoxia at 0.21 to 0.5 to mimic the oxygen fluctuations experienced by extremely low gestational-age neonates with acute hyperoxia exposure (25, 26) . However, there are no studies examining the minimum FiO 2 level that results in the suppression of VEGF. We therefore proposed the hypothesis that there exists a critical threshold of hyperoxia that suppresses regulators of Critical Po 2 affecting lung angiogenesis Articles angiogenesis in immature lungs. To test this hypothesis, we determined the response of systemic and pulmonary levels of VEGF and sVEGFR-1, as well as pulmonary angiogenesis gene profiles during graded oxygen exposure in newborn rat pups. Because male infants are at higher risk for respiratory complications (27) , we examined gender differences in response to graded oxygen.
RESULTS
Pooling of the pups for expanding litter sizes resulted in equal mean body weight and linear growth (crown to rump length) in all groups. There were no differences in mean lung wet weight or lung-to-body weight ratio after oxygen exposure. Table 1 lists the blood gas parameters (mixed venoarterial sample) in response to graded O 2 exposure. As expected, Po 2 levels increased significantly from 40% to 100% as compared with 21%, as did oxygen saturation (SaO 2 ), which increased earlier from 30% to 100% and was lower at 10%. Pco 2 was lower at 10%, 60%, 80%, 90%, and 100%. pH was lower at 10% and higher at 60%, 80%, and 100%. Base excess was lower at 10% and higher at 100%, and bicarbonate was lower only at 10%. The critical Po 2 associated with decreased lung VEGF was 103 mm Hg achieved with inspired O 2 of 60% ( Figure  1a) . Po 2 was inversely correlated with lung VEGF levels (R = −0.377; P < 0.008).
VEGF Levels
VEGF levels (pg/ml) in the serum are presented in Figure 1a (all groups) and Figure 1b (by gender). Serum VEGF was significantly increased at 70% inspired O 2 vs. 60% (264.3 ± 30.8; P < 0.01) and vs. 21% (136.8 ± 4.5). A similar increase at 70% was noted in females only (298.4 ± 46.0; P < 0.01) as compared with 21% (144.8 ± 3.2). Males had higher VEGF levels at 40% (184.3 ± 44.0; P < 0.01) as compared with females (149.9 ± 6.7), but lower levels at 70% (230.2 ± 38.3 vs. 298.4 ± 46.0; P < 0.05), 80% (122.3 ± 1.4 vs. 148.4 ± 4.8; P < 0.01), and 100% (146.1 ± 7.7 vs. 177.3 ± 5.7; P < 0.01). VEGF levels (pg/mg protein) in the lungs are presented in Figure 2a (all groups) and Figure 2b (by gender). As compared with 21% (178.2 ± 55.8), lung VEGF levels were lower at 10% (42.0 ± 4.2; P < 0.01), 60% (27.7 ± 6.3; P < 0.01), 70% (32.5 ± 7.3; P < 0.01), 80% (22.6 ± 4.6; P < 0.01), 90% (29.6 ± 5.3; P < 0.01), and 100% (26.0 ± 5.1; P < 0.01). No gender effect was noted because both genders responded similarly, with increased lung VEGF levels at 30% (male: 282.9 ± 123.2, P < 0.01; and female: 288.5 ± 85.6, P < 0.01) as compared with 21% (male: 90.6 ± 25.0, and female: 165.8 ± 45.4), followed by decreases at 60%-100%.
sVEGFR-1 Levels
In contrast to VEGF serum levels, sVEGFR-1 levels (pg/ml) in the serum are gender dependent, as shown in Figure 3a (all groups) and Figure 3b (by gender). Serum sVEGFR-1 levels declined at 30% (171.0 ± 61.4; P < 0.01) as compared with 21% (427.2 ± 19.7). A similar phenomenon occurred in males at 30% (146.6 ± 30.4; P < 0.01) as compared with 21% (443.3 ± 12.2), but not in females. Hypoxia (10% O 2 ) resulted in higher sVEGFR-1 levels in males (463.8 ± 56.4; P < 0.05) than in females (244.1 ± 51.2). Similarly, hyperoxia at 50% resulted in higher sVEGFR-1 levels in males (506.2 ± 97.8; P < 0.05) than in females (142.5 ± 79.5). Lung sVEGFR-1 levels (pg/mg protein) are presented in Figure 4a (all groups) and Figure 4b (by gender). Lung sVEGFR-1 levels declined at 70% (3243.8 ± 230.0; P < 0.01) as compared with 21% (7571.1 ± 230.6). In males, lung sVEGFR-1 levels were lower at 10% (4840.3 ± 214.9; P < 0.01), 30% (5454.5 ± 449.8; P < 0.05), 50% (5602.5 ± 385.0; P < 0.05), 70% (2885.5 ± 326.7; P < 0.01), and 80% (4036.7 ± 214.6; P < 0.01) than at 21% (7431.3 ± 291.4). In females, lung sVEGFR-1 levels were lower at 10% (6201.7 ± 127.5; P < 0.05), 70% (3602.2 ± 309.5; P < 0.01), and 80% (4597.2 ± 321.0; P < 0.05) than at 21% (7710.9 ± 245.0). Consistent with serum levels, sVEGFR-1 levels were lower in males at 10% (P < 0.002), but higher at 60% (6561.3 ± 355 vs. 4769.4 ± 173.4; P < 0.003) than in females.
Angiogenesis-Related Gene mRNA Expression
Tables 2-4 show the fold difference in lung angiogenesis genes from 21%. Table 2 represents the combined male and female data (n = 4 samples per group), and Tables 3 and 4 depict male and female responses, respectively. For the combined data, the genes that responded to changes in inspired O 2 from 10% to 100% with modest to robust upregulation were the antiangiogenesis-related collagen type XVIII α-1 (4-to 59-fold), endoglin (4-to 21-fold), matrix metalloproteinase-9 (2-to 5-fold), platelet-derived growth factor-α (6-to 18-fold), tissue inhibitor of metalloproteinase (TIMP)-3 (7-to 49-fold), and tumor necrosis factor-α (2-to 36-fold). Upregulation of most genes peaked at 70%, with the exception of endoglin and TIMP-3. Other genes that responded with upregulation SaO 2 68.9 ± 3.6** 74.7 ± 4.0 86.5 ± 2.5** 93.2 ± 1.6** 95.0 ± 1.4** 98.0 ± 1.0** 89.0 ± 3.6** 98.2 ± 0.75** 93.6 ± 1.8** 98.8 ± 0.3** Articles Keenaghan et al.
at 70% were angiopoietin-1 (9-fold), angiopoietin-2 (15-fold), collagen type IV (9-fold), insulin-like growth factor-1 (4-fold), leptin (25-fold), and VEGF-B (15-fold). Interleukin-1β was upregulated 6-, 9-, and 5-fold at 70%, 80%, and 90%, respectively ( Table 2) . Males exhibited a similar gene profile from 10% to 100%, but the effect was more robust. The most robust upregulation occurred at 70%, particularly for collagen type XVIII α-1 (1,068-fold), leptin (387-fold), and tumor necrosis factor-α (171-fold) ( Table 3) . By contrast, the angiogenesis gene profile differed in females, with moderate upregulation of most genes at 80%. These genes included cyclooxygenase-1 (15-fold), epidermal growth factor (18-fold), insulin-like growth factor-1 (15-fold), interleukin-1β (47-fold), interleukin-6 (8-fold), leptin (13-fold), matrix metalloproteinase-2 (18-fold), platelet-derived growth factor-α (23-fold), TIMP-1 (19-fold), TIMP-2 (20-fold), TIMP-3 (14-fold), tumor necrosis factor-α (13-fold), and VEGFR-1 (27-fold) ( Table 4 ).
DISCUSSION
The current study was conducted to test the hypothesis that there exists a critical threshold of hyperoxia that alters the factors regulating lung angiogenesis. Our study is the first to demonstrate a response of systemic and pulmonary angiogenesis biomarkers and genes to graded inspired O 2 and Po 2 levels.
Despite the short (2 h) exposure, we demonstrated that Po 2 and SaO 2 were directly correlated with hyperoxia and inversely correlated with VEGF levels in the lungs but not in the systemic circulation. Nonlinear regression analysis revealed that the critical Po 2 associated with decreased lung VEGF (57% from normoxia) was 66 mm Hg achieved with a FiO 2 of 0.4. sVEGFR-1, the endogenous negative regulator of VEGF action, did not change as a function of Po 2 or SaO 2 . We did not establish a relationship between systemic or pulmonary VEGF and sVEGFR-1. There was a robust elevation of mRNA expression for all angiogenesis genes at 70% O 2 , which was predominant in males. Taken together, these findings prove our hypothesis and enable us to conclude that exposure of immature lungs to even short periods of inspired O 2 >40% will alter biomarkers and genes that regulate lung angiogenesis. Rats born at term are in the late cannalicular to saccular stage of lung development (28) . This corresponds to a gestational age of 24-30 wk in human lung development. BPD primarily occurs in this group of neonates (29) . Therefore, the newborn rat is a good model to study the effects of graded hyperoxia on lung angiogenesis. The first test of our hypothesis demonstrated that serum levels tended to increase as a function of increasing (32) showed that in tracheal aspirates of premature infants with respiratory distress syndrome, VEGF levels increased early during the first 12 h of life and followed a pattern in which there was an initial spike, followed by a decline, and then a subsequent rise, by days 21-28, in those neonates with an adverse outcome. Our serum data seem to have a similar biphasic response, with minor peaks at 30% and 40%, a decline at 50% and 60%, and a second peak at 70%. The serum VEGF profile across the range of inspired O 2 was consistent between genders. One interesting finding was the response of lung VEGF, which peaked at 30% and then declined at 40% to reach significance at 60%-100% O 2 . This finding demonstrates differences between the systemic and pulmonary responses to short-term oxygen exposure, with initial pulmonary compensatory elevations in VEGF occurring at a much lower FiO 2 . This result is important because it leads to speculation that biomarkers of angiogenesis in the systemic circulation may not be entirely representative of pulmonary responses. The differences in responses between the lungs and the serum may occur because the lungs are in direct contact with oxygen and, thus, the peaks occur earlier. Nevertheless, O 2 exposure of >30%, even after only 2 h, leads to the suppression of pulmonary VEGF, which may ultimately result in aberrant angiogenesis and implies the need for further consideration of neonatal resuscitation.
VEGFR-1 is the respective tyrosine kinase receptor needed for VEGF to act physiologically (20, 23, 24, 33) . sVEGFR-1 is the splice variant of the VEGFR-1, which acts as a VEGF "trap" (21) . The next test of our hypothesis involved the response of serum and pulmonary sVEGFR-1 to graded inspired O 2 . Of note, the systemic levels declined with 30%, whereas the pulmonary levels declined at 70%, although the response was not sustained. This result was in contrast to systemic and pulmonary VEGF, which increased at 70% and 30%, respectively. This finding strengthens the concept that sVEGFR-1 is antagonistic to VEGF. It is possible that a longer exposure to increased oxygen concentrations would have resulted in lower levels, as demonstrated by Feng et al. (34) . Resumption of baseline levels would further inhibit the function of VEGF. The final test of our hypothesis was the response of pulmonary angiogenesis genes to inspired O 2 . The data revealed that a majority of genes were upregulated at 70%, but the most predominant effect was noted in males. At 70%, the antiangiogenic collagen type XVIII was robustly upregulated, whereas endoglin, an endothelial cell specification gene, was downregulated. In males, the negative regulators of angiogenesis were mostly upregulated. These included angiopoietin 1 and 2, which control blood vessel development and stability (35) , collagen type XVIII, and TIMP-3, thus providing evidence for one of the mechanisms explaining why male infants are at higher risk for respiratory complications. In females, the response of angiogenesis genes occurred at a higher FiO 2 of 0.8 and was significantly less The data are presented as fold expression difference as compared with pups exposed to 21% oxygen. All data were corrected using five different housekeeping genes. Genes are selected from a profile of 84 genes. In alphabetical order, the genes of interest are: Ang (angiopoietin) -1 and -2; col (collagen) type IV and -type XVIII; cOX (cyclooxygenase) 
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Articles robust, suggesting that females are more resistant to the effects of hyperoxia. Gender dimorphism may suggest a key role for gender hormones. Estrogen has been shown to be a potent stimulator of VEGF and angiogenesis, rendering a protective effect in females (36) . Despite the important clinical implications of this study, there were some limitations, including the use of mixed arterial-venous blood to determine blood gases. Arterial blood sampling in the neonatal rat is difficult; therefore, we opted to collect mixed venous-arterial blood immediately after killing the pups by decapitation. Better results would have been obtained with pure arterial sampling. Nevertheless, our study showed that short-term exposure to graded inspired O 2 may result in compensatory increases in angiogenic and antiangiogenic factors, which are mostly associated with the suppression of vessel sprouting. Exposure of the immature lungs to even short periods of inspired O 2 >40% will have a negative impact on lung angiogenesis and may increase the risk for the development of BPD. 
METHODS

Experimental Design
Certified infection-free timed-pregnant Sprague Dawley rats (200-300 g) carrying fetuses (9-15) of known gestational age (18 d) were purchased from Charles River Laboratories (Wilmington, MA). The pregnant rats were placed in cages compliant with the U.S. Department of Agriculture guidelines and allowed to stabilize for 48 h; they then remained undisturbed until the birth of their pups. The animals were housed in a 12-h day/12-h night cycle and were provided standard laboratory diet and water ad libitum. Within 2-6 h of birth, newborn pups delivered on the same day were pooled and randomly assigned to an expanded litter of 16 pups per litter to simulate the nutritional status of extremely low gestational-age neonates. Each pup was weighed and measured for linear growth (crown to rump length) and randomly assigned to 10%, 21%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 100% oxygen exposure for 2 h (n = 16 pups per group). For hypoxia and hyperoxia exposure, the newborn rat pups and dams were placed in a specialized oxygen chamber, and the oxygen environment was maintained using an oxycycler (BioSpherix, Lacona, NY). At the end of the hypoxic, normoxic, or hyperoxic episode, the rat pups were immediately killed by decapitation. Blood samples (from 6 males and 6 females, respectively) were analyzed for blood gases and SaO 2 using an i-Stat portable blood gas instrument (Abbot Laboratories, Abbot Park, IL). Blood samples (pooled for a total of 4 males and 4 females) and lung samples (from 6 males and 6 females, respectively) were analyzed for VEGF and sVEGFR-1 levels using enzyme immunoassay. Biopsy of the lung samples was carried out from the left lobe, rinsed in ice-cold phosphate-buffered saline, and snap-frozen in liquid nitrogen for mRNA expression of genes regulating angiogenesis using quantitative real-time PCR arrays (2 males and 2 females).
Assay of VEGF and sVEGFR-1
To determine the levels of VEGF and sVEGFR-1 in serum, blood samples were collected in sterile polypropylene tubes and allowed to clot on ice for 30 min before centrifugation at 3,000 rpm at 4 °C. The resulting serum was transferred to a clean, sterile polypropylene tube and frozen at −20 °C until assay. Immediately after the animals were killed, the whole lungs were removed and the wet weight was determined. Tissue samples were excised from the left lower lobe, rinsed several times in ice-cold phosphate-buffered saline until all evidence of blood elements was removed, snap-frozen in liquid nitrogen, and stored at −80 °C before assay. For VEGF and sVEGFR-1 levels, lung samples were placed in 2 ml of sterile 
